By Medpage Today | July 06, 2017
Cardiogenic shock, no-reflow still problems in 90-year-olds.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...
A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...
